Showing results (151-160 of 242) with videos related to

Sort By:
Pageof 25
Plos One|November 1, 2018
Prevalence of abnormal glucose metabolism in pediatric acute, acute recurrent and chronic pancreatitisMaisam Abu-El-Haija, Lindsey Hornung, Lee A Denson, et al.
Blood|March 14, 2009
Granulocyte/macrophage-colony-stimulating factor autoantibodies and myeloid cell immune functions in healthy subjectsKanji Uchida, Koh Nakata, Takuji Suzuki, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 13, 2024
The Role of Pancreatitis Risk Genes in Endocrine Insufficiency Development After Acute Pancreatitis in ChildrenMaisam Abu-El-Haija, Wenying Zhang, Rebekah Karns, et al.
Journal of Pediatric Gastroenterology and Nutrition|July 2, 2025
Acute pancreatitis gut dysbiosis persists at 1-year follow-up and is associated with clinical outcomesChinenye R Dike, Qing Duan, Faizan Ahmed, et al.
Immunity|January 31, 2024
Microbiota-derived butyrate restricts tuft cell differentiation via histone deacetylase 3 to modulate intestinal type 2 immunityEmily M Eshleman, Taylor Rice, Crystal Potter, et al.
The New England Journal of Medicine|February 9, 2007
GM-CSF autoantibodies and neutrophil dysfunction in pulmonary alveolar proteinosisKanji Uchida, David C Beck, Takashi Yamamoto, et al.
Alimentary Pharmacology & Therapeutics|December 22, 2021
Antibodies-to-infliximab accelerate clearance while dose intensification reverses immunogenicity and recaptures clinical response in paediatric Crohn's diseaseRuben J Colman, Ye Xiong, Tomoyuki Mizuno, et al.
Biorxiv : the Preprint Server for Biology|October 3, 2025
Epithelial-intrinsic nitric oxide synthase 2 sustains host-microbiota dynamics that promote colitisSeika Hashimoto-Hill, Bryce Hunt, Sekani Cole, et al.
BMJ Open Quality|February 17, 2018
Improving a process to obtain hepatitis B serology among patients treated with infliximab at a large urban children's hospitalM Raphaelle Jean, Ann Weaver, Teresa Mastin-Diebold, et al.
Medrxiv : the Preprint Server for Health Sciences|June 9, 2020
Reduced expression of COVID-19 host receptor, <i>ACE2</i> is associated with small bowel inflammation, more severe disease, and response to anti-TNF therapy in Crohn's diseaseAlka A Potdar, Shishir Dube, Takeo Naito, et al.
Pageof 25